(Q77751620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

D T Scadden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D P Schenkein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Z Bernstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

B Luskey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Doweiko

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Tulpule

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A M Levine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

2580-2587

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

Impact of opportunistic disease on survival in patients with HIV infection

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Diagnosis and management of systemic non-Hodgkin's lymphoma in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Non-Hodgkin's lymphoma in a population with or at risk for acquired immunodeficiency syndrome: indications for intensive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

AIDS-associated non-Hodgkin's lymphoma in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2580%3A%3AAID-CNCR25%3E3.0.CO%3B2-C

10.1002/(SICI)1097-0142(19981215)83:12<2580::AID-CNCR25>3.0.CO;2-C

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874466%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference